SEER–Medicare analysis showed persistent adjusted racial gaps in curative-intent treatment for early-stage NSCLC, with Black patients less likely to receive surgery or radiotherapy across 2005–2019.
Please provide your email address to receive an email when new articles are posted on . Patients with neovascular age-related macular degeneration who have responded poorly to anti-VEGF monotherapy ...
David Kuter, MD, DPhil discusses Wayrilz™ (rilzabrutinib), a new FDA-approved treatment for persistent or chronic immune thrombocytopenia (ITP). Dr Kuter is the Director of Clinical Hematology at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results